Vendis Capital partners with BitterLiebe, a leading health supplements brand, to accelerate its growth and expand internationally within the gastrointestinal health market.

Target Information

BitterLiebe, headquartered in Mannheim, Germany, is a prominent direct-to-consumer brand specializing in premium health supplements aimed at gastrointestinal health. Founded in 2018 by Andre Sierek and Jan Stratmann, the brand leverages natural bitter substances as core ingredients to meet the rising consumer demand for gut health solutions. Since its inception, BitterLiebe has witnessed substantial growth fueled by innovative product offerings and a multifaceted distribution approach. The brand has been supported by ARCUS Capital, a family equity investor based in Munich, since 2020, and utilized the expertise of Start Now Consulting GmbH led by Judith Williams from its early days.

The company's diverse product range includes bitter drops, sprays, capsules, and powders, which are supplemented by probiotics and natural vitamins and minerals. BitterLiebe has developed a robust knowledge platform focusing on gastrointestinal health, fostering strong customer loyalty and attracting new clients. Initially successful with its e-commerce platform, BitterLiebe has expanded its reach to more than 6,000 offline sales points across drugstores and food retailers.

Industry Overview in Germany

The dietary supplement industry in Germany has experienced significant growth, propelled by an increasing awareness of health and wellness among consumers. The market is characterized by a shift towards natural products, with more individuals seek

View Source

Similar Deals

NPM Capital Elbfrost

2025

Growth Equity & Expansion Capital Frozen Food Manufacturing Germany
Q·CAPITAL VENTURES fresh five* premiumfood Ltd.

2023

Growth Equity & Expansion Capital Vegan & Vegetarian Food Manufacturing Germany
QC·VENTURES fresh five* premiumfood GmbH

2023

Growth Equity & Expansion Capital Special Foods & Wellbeing Products Germany
European Circular Bioeconomy Fund Prolupin

2023

Growth Equity & Expansion Capital Vegan & Vegetarian Food Manufacturing Germany
Odewald KMU Karl Schmidt GmbH

2023

Growth Equity & Expansion Capital Food Retail & Distribution (NEC) Germany
Project A WindStar Medical

2020

Growth Equity & Expansion Capital Retail - Drugs without Grocery Germany

Vendis Capital

invested in

BitterLiebe

in 2023

in a Growth Equity & Expansion Capital deal

Disclosed details

Transaction Size: $320M

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert